Knight Therapeutics
Signal active
Investment Firm
Overview
Knight Therapeutics is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the markets.
Highlights
Founded
1995
Industry
Biotechnology
Employees
501-1000
Investment
4
Lead Investment
2
Exits
4
Stages
N/A
Investor Type
N/A
Location
North America
Contact Information
Social
Profile Resume
Knight Therapeutics, established in 1995 and headquartered in North America., specializes in investments across Biotechnology, Pharmaceutical, Health Diagnostics, Impact Investing, Asset Management, Health Care, Medical Device, Venture Capital, Life Science, Financial Services. The organization boasts a portfolio of 4 investments, with an average round size of $16.7M and 4 successful exits. Their recent investments include Advaxis, Sectoral Asset Management, Profound Medical Inc, Genesys Capital, BDC Healthcare Venture. The highest investment round they participated in was $2.6B. Among their most notable exits are Advaxis and Sectoral Asset Management. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Knight Therapeutics has made 4 investments. Their most recent investment was on Jan 25, 2016, when INTEGA Skin Sciences raised $8.6M.
Knight Therapeutics has made 1 diversity investments. Their most recent diversity investment was on Aug 26, 2015, when Advaxis raised $25.0M.
investments
4
Diversity investments
1
Lead investments
2
Number of exits
4
Investments
4
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 30, 2015 | Profound Medical Inc | Health Care | 23.2M |
| Aug 26, 2015 | Advaxis | Biotechnology | 25.0M |
| Jan 25, 2016 | INTEGA Skin Sciences | Pharmaceutical | 8.6M |
| Aug 10, 2017 | - | - | 10.0M |
Profound Medical Inc
INTEGA Skin SciencesExits
4
Funding Timeline
Funding rounds
4
Investors
3
Funds
0
Funding Rounds
4
Knight Therapeutics has raised 4 rounds. Their latest funding was raised on Aug 10, 2017 from a Post-IPO Debt - Synergy CHC round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 30, 2015 | Venture Round - Profound Medical Inc | - | 23.2M | - |
| Aug 26, 2015 | Post-IPO Equity - Advaxis | - | 25.0M | - |
| Jan 25, 2016 | Debt Financing - INTEGA Skin Sciences | - | 8.6M | - |
| Aug 10, 2017 | Post-IPO Debt - Synergy CHC | - | 10.0M | - |
Investors
7
Knight Therapeutics is funded by 7 investor(s). International Finance Corporation and Long Zone Holdings Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
| - | No | Post-IPO Equity - Knight Therapeutics | 74.2M |
| - | No | Secondary Market - Knight Therapeutics | 0 |
Long Zone Holdings | Yes | Post-IPO Equity - Knight Therapeutics | 627.4K |
International Finance Corporation | Yes | Post-IPO Debt - Knight Therapeutics | 38.5M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.